We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

tDCS Combined With Constraint Induced Movement Therapy and Role of GABA Activity in Stroke Recovery

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01983319
Recruitment Status : Completed
First Posted : November 13, 2013
Last Update Posted : February 7, 2017
Sponsor:
Collaborators:
Information provided by (Responsible Party):

Study Description
Brief Summary:
The aim of this study is to determine whether noninvasive brain stimulation in form of active transcranial direct current stimulation (tDCS) combined with constraint induced movement therapy (CIMT) offers an additional benefit as compared with sham tDCS combined with CIMT in patients with stroke. Furthermore the purpose is to highlight changes in GABA activity more than 3 months after stroke and its importance for effect of tDCS and CIMT combined with tDCS.

Condition or disease Intervention/treatment
Stroke Device: active anodal transcranial Direct Current Stimulation (tDCS) Device: sham transcranial Direct Current Stimulation Behavioral: Constraint Induced Movement Therapy (CIMT)

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 64 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Double (Participant, Care Provider)
Primary Purpose: Treatment
Official Title: Transcranial Direct Current Stimulation Combined With Constraint Induced Movement Therapy and Role of GABA Activity in Stroke Recovery
Study Start Date : January 2014
Primary Completion Date : December 2015
Study Completion Date : December 2015
Arms and Interventions

Arm Intervention/treatment
Experimental: CIMT + active anodal tDCS
Subjects in this group will be trained with constraint-induced movement therapy for the hand (10 consecutive sessions Monday- Friday) while concurrently receiving active anodal transcranial Direct Current Stimulation 1,5 mA for 30 min.
Device: active anodal transcranial Direct Current Stimulation (tDCS)
Anodal transcranial Direct Current Stimulation 1.5 mA in 30 minutes with CIMT
Other Names:
  • tDCS
  • Non invasive brain stimulation
  • transcranial stimulation
Behavioral: Constraint Induced Movement Therapy (CIMT)
2 weeks of CIMT
Other Name: CIMT
Sham Comparator: CIMT + sham tDCS
Subjects in this group will be trained with constraint-induced movement therapy for the hand (10 consecutive sessions Monday- Friday) while concurrently receiving sham transcranial Direct Current Stimulation
Device: sham transcranial Direct Current Stimulation
sham transcranial Direct Current Stimulation 30 min with CIMT
Other Name: placebo stimulation
Behavioral: Constraint Induced Movement Therapy (CIMT)
2 weeks of CIMT
Other Name: CIMT
No Intervention: Healthy control subjects
20 healthy age-matched control subjects will undergo MRI spectroscopy of the brain.


Outcome Measures

Primary Outcome Measures :
  1. Change in Upper Limb function [ Time Frame: Baseline and posttest (an average of 2 weeks from baseline) ]
    The motor function assessment will be done with: Wolf Motor Function Test


Secondary Outcome Measures :
  1. GABA (gamma-aminobutyric acid) activity [ Time Frame: Baseline ]
    Assessment of GABA activity using MRI spectroscopy. Measurements will be compared between patients undergoing CIMT and healthy subjects.


Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • stroke onset >3 months prior to study enrollment
  • subject has at least 10 degrees mobility over wrist, thumb and fingers on the affected side
  • subject can move, stand up and stand firmly with constrained healthy hand
  • subject can perform training 6 hours daily in 2 weeks
  • subject is able to understand instructions and be able to cooperate

Exclusion Criteria:

  • pregnancy
  • contraindications to MRI of brain
  • epilepsy, major psychiatric disease
  • excessive pain that prevents training
  • history of other diseases resulting decreased mobility of affected upper limb
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01983319


Locations
Denmark
Regionhospital Hammel Neurocenter, Research Unit
Hammel, Denmark, 8450
Sponsors and Collaborators
University of Aarhus
Regionshospitalet Hammel Neurocenter
Aarhus University Hospital
Investigators
Study Director: Henning Andersen, Professor Aarhus University Hospital
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Krystian Figlewski, MD, University of Aarhus
ClinicalTrials.gov Identifier: NCT01983319     History of Changes
Other Study ID Numbers: M-2013-268-13
First Posted: November 13, 2013    Key Record Dates
Last Update Posted: February 7, 2017
Last Verified: February 2017

Additional relevant MeSH terms:
Stroke
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases